A recent study demonstrated that the gene deletion or the pharmacological inhibition of TRPC6 ameliorated skeletal and cardiac muscle defects and bone deformities in double knockout mice for both dystrophin and utrophin (mdx/utrn−/−), constituting a severe DMD model [73]. Here, TRPC6 is linked to Duchenne muscular dystrophy.